Altamira Therapeutics's total assets for Q were $7.69M, an increase of 22.08% from the previous quarter. CYTOF total liabilities were $1.24M for the fiscal quarter, a -91.82% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.